Does DABRAFENIB Cause Neoplasm malignant? 200 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Neoplasm malignant have been filed in association with DABRAFENIB (Tafinlar). This represents 1.0% of all adverse event reports for DABRAFENIB.
200
Reports of Neoplasm malignant with DABRAFENIB
1.0%
of all DABRAFENIB reports
47
Deaths
34
Hospitalizations
How Dangerous Is Neoplasm malignant From DABRAFENIB?
Of the 200 reports, 47 (23.5%) resulted in death, 34 (17.0%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DABRAFENIB Alternatives Have Lower Neoplasm malignant Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB